Patent · US Active

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

US10357505B2 · kind B2 · utility

0Cited by
11References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2017
Grant dateJul 23, 2019
Priority date
Expiry dateJul 17, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/6561
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.